While the previous CEO, Nader, had a great drug but moved forward like a professional scammer and burned down our great chances for HIV and COVID, the new future CEO is of a different calibre. He keeps quiet most of the time- good, but not good enough! A few days ago, the last information was excellent and confirmed with possible certainty by top external doctors that the drug has a great future for many, if not countless, diseases. All the available results are great - of course, from a formal view, not good enough for approval any time soon, in fact, years away.
Unfortunately, at the end of the call, unnecessary info about the "FDA- hold" and partnerships was released, which gives shorters a clear timeline about their timeframe for continuous shorting. I thought Cyrus would have learned his lessons in the past- obviously not. Shorters and MMs are starting to love him. This was unnecessary favour for them.
We don't need info about the following:
* Amarex: we know they will pay when the time comes. The announcement will come as a surprise.
* FDA- Hold: time will come, maybe in 4 weeks, maybe in 2 months. No need to talk about it. The "hold" will be released. keep quiet.
* Partnership: will come for Oncology, the last info gives me a 100% certainty. We know it will not happen before lifting the "Hold"
I believe it will take us to mid of February before we will see sp moving up again - in the meantime shorters will play us with pleasure as president is talking too much about timelines.
Market Data 
Markets 
AI
